References
- Australian Government Department of Health. BreastScreen Australia. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/about-breast-screening. Last accessed June 17, 2020
- Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;(6):CD001877
- D'Orsi CJ, Sickles EA, Mendelson EB, Morris EA, eds. ACR BI-RADS Atlas: Breast Imaging Reporting and Data System, 5th edition. Reston: American College of Radiology, 2013
- Sprague BL, Conant EF, Onega T, et al. Variation in mammographic breast density assessments among radiologists in clinical practice: a multicenter observational study. Ann Intern Med 2016;165:457–64
- Melnikow J, Fenton JJ, Whitlock EP, et al. Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2016;164:268–78
- Destounis S, Johnston L, Highnam R, Arieno A, Morgan R, Chan A. Using volumetric breast density to quantify the potential masking risk of mammographic density. Am J Roentgenol 2017;208:222–7
- Winkler NS, Raza S, Mackesy M, Birdwell RL. Breast density: clinical implications and assessment methods. Radiographics 2015;35:316–24
- Eng A, Gallant Z, Shepherd J, et al. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res 2014;16:439
- Alonzo-Proulx O, Mawdsley GE, Patrie JT, Yaffe MJ, Harvey JA. Reliability of automated breast density measurements. Radiology 2015;275:366–76
- Conant EF, Sprague BL, Kontos D. Beyond BI-RADS density: a call for quantification in the breast imaging clinic. Radiology 2018;286:401–4
- Stone J, Ding J, Warren RM, Duffy SW, Hopper JL. Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 2010;12:R97
- Wanders JOP, Holland K, Karssemeijer N, et al. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study. Breast Cancer Res 2017;19:67
- Krishnan K, Baglietto L, Apicella C, et al. Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study. Breast Cancer Res 2016;18:63
- Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014;106:dju255
- Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886–94
- Stone J, Dite GS, Gunasekara A, et al. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev 2006;15:612–17
- McCormack VA, Perry NM, Vinnicombe SJ, Dos Santos Silva I. Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging: a UK longitudinal study. Int J Cancer 2010;127:452–61
- Bell RJ, Evans J, Fox J, Pridmore V. Using an automated measure of breast density to explore the association between ethnicity and mammographic density in Australian women. J Med Imaging Radiat Oncol 2019;63:183–9
- Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227–36
- Butler RS. Invited commentary: The breast density dilemma–challenges, lessons, and future directions. Radiographics 2015;35:324–6
- Kavanagh AM, Byrnes GB, Nickson C, et al. Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomarkers Prev 2008;17:2818–24
- McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159–69
- Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133–44
- Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 2013;31:2249–56
- Boyd NF, Martin LJ, Li Q, et al. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:961–6
- Byrne C, Ursin G, Martin CF, et al. Mammographic density change with estrogen and progestin therapy and breast cancer risk. J Natl Cancer Inst 2017;109:djx001
- Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004;96:621–8
- Cuzick J, Warwick J, Pinney E, et al. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 2011;103:744–52
- Ramon YCT, Chirivella I, Miranda J, et al. Mammographic density and breast cancer in women from high risk families. Breast Cancer Res 2015;17:93
- Stone J, Thompson DJ, Dos Santos Silva I, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res 2015;75:2457–67
- https://seer.cancer.gov/archive/csr/1975_2014/results_merged/topic_race_ethnicity.pdf.
- El-Bastawissi AY, White E, Mandelson MT, Taplin S. Variation in mammographic breast density by race. Ann Epidemiol 2001;11:257–63
- Martin LJ, Melnichouk O, Guo H, et al. Family history, mammographic density, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2010;19:456–63
- Rice MS, Bertrand KA, VanderWeele TJ, et al. Mammographic density and breast cancer risk: a mediation analysis. Breast Cancer Res 2016;18:94
- DenseBreast-info. https://densebreast-info.org/. Last accessed June 17, 2020
- Colin C, Schott AM, Valette PJ. Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening. Eur Radiol 2014;24:2412–16
- Breast Cancer Network Australia. Mammographic density and screening. https://www.bcna.org.au/breast-health-awareness/mammographic-density-and-screening/. Last accessed June 17, 2020
- Sickles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin North Am 2010;48:859–78
- Freer PE. Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics 2015;35:302–15
- Australian Government. Cancer Australia. Risk factors for breast cancer: a review of the evidence. 2018. https://canceraustralia.gov.au/system/tdf/publications/risk-factors-breast-cancer-review-evidence-2018/pdf/rfbcr_risk_factors_for_breast_cancer_a_review_of_the_evidence_2018_report.pdf?file=1&type=node&id=6421. Last accessed June 17, 2020
- Tice JA, Cummings SR, Smith-Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008;148:337–47
- Gierach GL, Ichikawa L, Kerlikowske K, et al. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2012;104:1218–27
- Zhang S, Ivy JS, Diehl KM, Yankaskas BC. The association of breast density with breast cancer mortality in African American and white women screened in community practice. Breast Cancer Res Treat 2013;137:273–83
- Keating NL, Pace LE. New federal requirements to inform patients about breast density: will they help patients? JAMA 2019;321:2275–6
- Saulsberry L, Pace LE, Keating NL. The impact of breast density notification laws on supplemental breast imaging and breast biopsy. J Gen Intern Med 2019;34:1441–51
- Brown J, Soukas C, Lin JJ, Margolies L, Santiago-Rivas M, Jandorf L. Physician knowledge, attitudes, and practices regarding breast density. J Womens Health (Larchmt) 2019;28:1193–9
- Gunn CM, Kressin NR, Cooper K, Marturano C, Freund KM, Battaglia TA. Primary care provider experience with breast density legislation in Massachusetts. J Womens Health (Larchmt) 2018;27:615–22
- BreastScreen Australia. Position Statement on Breast Density and Screening within the BreastScreen Australia Program. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/br-policy-breast-density. Last accessed June 17, 2020
- Cording J, Smith A, Gribble A, Bishop S. Breast density: A literature review to inform BreastScreen Australia’s position statement on breast density and screening. 2018. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/0C586AE66702F52DCA258367001498DA/$File/Breast%20Density%20-%20A%20literature%20review.pdf. Last accessed June 17, 2020
- BreastScreen Australia. Position Statement on the use of Tomosynthesis within BreastScreen Australia Services. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/EEF21D9C3CA10CFECA257DCD00068D22/$File/Tomosynthesis%20-%20Position%20Statement.pdf. Last accessed June 17, 2020
- Kaiser Health News. A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms. 2019. https://khn.org/news/a-million-dollar-marketing-juggernaut-pushes-3d-mammograms/. Last accessed June 17, 2020
- ECOG-ACRIN. TMIST. Breast cancer trial. Screening mammography. https://ecog-acrin.org/tmist. Last accessed June 17, 2020
- Sprague BL, Stout NK, Schechter C, et al. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med 2015;162:157–66
- Farshid G. Routine reporting of mammographic density from screening mammograms. ANZ J Surg 2017;87:965–7
- Ohuchi N, Suzuki A, Sobue T, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet 2016;387:341–8
- Clinicaltrials.gov. Breast cancer screening with MRI in women aged 50-75 years with extremely dense breast tissue: the DENSE Trial. https://clinicaltrials.gov/ct2/show/NCT01315015. Last accessed June 17, 2020
- Netherlands trial using the Volpara® Density™ clinical application reports initial results at the European Congress of Radiology. 2019. http://member.afraccess.com/media?id=CMN://2A1136678&filename = 20190304/VHT_02082832.pdf. Last accessed June 17, 2020
- Bakker MF, de Lange SV, Pijnappel RM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 2019;381:2091–102
- Longo DL. Detecting breast cancer in women with dense breasts. N Engl J Med 2019;381:2169–70
- Stone J. Should breast cancer screening programs routinely measure mammographic density? J Med Imaging Radiat Oncol 2018;62:151–8
- American Cancer Society. Tamoxifen and Raloxifene for Lowering Breast Cancer Risk. https://www.cancer.org/cancer/breast-cancer/risk-and-prevention/tamoxifen-and-raloxifene-for-breast-cancer-prevention.html. Last accessed June 17, 2020
- Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 2000;78:181–6
- Kieback DG, Harbeck N, Bauer W, et al. Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy. Gynecol Oncol 2010;119:500–5
- American Cancer Society. Deciding whether to use medicine to reduce breast cancer risk. https://www.cancer.org/cancer/breast-cancer/risk-and-prevention/deciding-whether-to-use-medicine-to-reduce-breast-cancer-risk.html. Last accessed June 17, 2020
- Gail Model for breasst cancer risk. https://www.mdcalc.com/gail-model-breast-cancer-risk. Last accessed June 17, 2020
- International Breast Cancer Intervention Study.Online Tyrer-Cuzick Model breast cancer risk evaluation tool. https://ibis.ikonopedia.com/. Last accessed June 17, 2020
- Breast Cancer Surveillance Consortium Risk Calculator. https://tools.bcsc-scc.org/BC5yearRisk/intro.htm. Last accessed June 17, 2020
- Brentnall AR, Cuzick J, Buist DSM, Bowles EJA. Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density. JAMA Oncol 2018;4:e180174
- Kerlikowske K, Zhu W, Tosteson AN, et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med 2015;162:673–81
- Kerlikowske K, Sprague BL, Tosteson ANA, et al. Strategies to identify women at high risk of advanced breast cancer during routine screening for discussion of supplemental imaging. JAMA Intern Med 2019;179:1230–9
- Richman IB, Busch SH. Advising women about supplemental screening after dense breast notification: still no easy answers. JAMA Intern Med 2019 Jul 1. Epub ahead of print
- Schunemann HJ, Lerda D, Quinn C, et al.; European Commission Initiative on Breast Cancer Contributor Group. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med 2020;172:46–56
- US Preventive Services Task Force. Final Recommendation Statement. Breast Cancer: Screening. January 11, 2016. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening. Last accessed June 17, 2020